PTPN11 and neoplasm: Combination of anti-human PD1 antibody with SHP2 inhibitors showed combinatorial benefit on enhancing immune cells-mediated tumor killing in co-culture of OVCAR-8 spheroids with activated PBMCs, while PD1 antibody did not show any single-agent effect (Supplementary Fig. 10a,b).